Revvity (MEX:PKI) Moat Score: 6/10 (As of Jul. 02, 2026)


MEX:PKI Revvity Inc MEX:PKI
77 GF Score
Price MXN1,644.85
GF Value MXN1,756.65
! 11 Warning Signs
View Full Analysis

What is Revvity Moat Score?

Revvity MEX:PKI 77 Moat Score is 6 as of Jul. 02, 2026. GuruFocus rates MEX:PKI with a GF Score™ of 77/100 and a GF Value™ of MXN1,756.65. The stock has 11 warning signs investors should review. Among 216 Medical Diagnostics & Research companies, Revvity ranks better than 93.98% on this metric.

Revvity has the Moat Score of 6, which implies that the company might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Revvity has Narrow Moat: Revvity Inc has a strong narrow moat due to its valuable intellectual property and consistent innovation in its field. The company benefits from customer loyalty and some pricing power, but lacks the scale or regulatory barriers for a wide moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Revvity might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Revvity  (MEX:PKI) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Revvity Moat Score Related Terms

MEX:PKI vs ICLR, CRL, MEDP: Moat Score Comparison

For the Diagnostics & Research subindustry, Revvity's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Revvity Moat Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Revvity's Moat Score distribution charts can be found below:

* The bar in red indicates where Revvity's Moat Score falls into.


MEX:PKI
77GF Score
Revvity Inc MEX:PKI
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 6 mean?
Revvity (MEX:PKI) has a Moat Score of 6 as of Jul. 02, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Revvity ranks #13 out of 216 companies in the Medical Diagnostics & Research industry, placing it in the top 6%.
Is Revvity's Moat Score too high?
Revvity's current Moat Score is 6. Based on the distribution chart, Revvity ranks #13 out of 216 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Revvity has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Revvity's Moat Score compare to ICLR and CRL?
According to the Medical Diagnostics & Research industry distribution chart, Revvity ranks #13 out of 216 companies for Moat Score. This places Revvity in the top 6% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Diagnostics & Research company?
A good Moat Score depends on the Medical Diagnostics & Research industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Revvity's current Moat Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revvity stock overvalued right now?
Revvity (MEX:PKI) has a current Moat Score of 6. The stock's GF Value™ is MXN1,756.65, compared to a current price of MXN1,644.85 — trading 6.4% below its estimated fair value. The current Moat Score is 6. Revvity's overall GF Score™ is 77/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Revvity (MEX:PKI), the current Moat Score is 6 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Revvity (MEX:PKI) Overvalued in 2026?

Based on GuruFocus' analysis, Revvity stock appears to be undervalued. The current stock price of MXN1,644.85 is trading 6.4% below its estimated GF Value™ of MXN1,756.65.

Key valuation signals for MEX:PKI:

  • Moat Score: 6
  • GF Value™: MXN1,756.65 vs. price of MXN1,644.85 (6.4% below fair value)
  • GF Score™: 77/100 with 11 warning signs

No single metric tells the full story. See the MEX:PKI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Revvity Business Description

Address 77 4th Avenue, Waltham, MA, USA, 02451
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
77GF Score

Get the complete analysis for MEX:PKI

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,644.85
Price
MXN1,756.65
GF Value